Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5437620

CCCCOc1ccc(CC(=O)N2CCC3(CCN(Cc4ccccc4OCC(C)C)C3)CC2)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CCR8 P51685 2/20 0.49
KCNH2 Q12809 2/20 0.49
GHSR Q92847 6/20 0.47
MEN1 O00255 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP2D6 P10635 5/20 0.42
CYP3A4 P08684 4/20 0.42
TSHR P16473 3/20 0.42
KDM4E B2RXH2 1/20 0.42
ALOX15 P16050 1/20 0.42
CYP2C19 P33261 1/20 0.42
USP2 O75604 1/20 0.42
HRH2 P25021 1/20 0.42
HRH1 P35367 1/20 0.42
CYP1A2 P05177 1/20 0.42
HIF1A Q16665 1/20 0.41
CHRM2 P08172 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5446423 0.95 CCR8 (0.51) CCR8KCNH2GHSRMEN1KMT2A
SCHEMBL5399989 0.95 CCR8 (0.54) CCR8KCNH2GHSRMEN1KMT2A
Trifluoroacetic Acid SCHEMBL5442840 0.91 CCR8 (0.51) CCR8KCNH2GHSRMEN1KMT2A
SCHEMBL5405497 0.90 CCR8 (0.56) CCR8KCNH2GHSRCYP2D6CYP3A4
Trifluoroacetic Acid SCHEMBL5433618 0.90 CCR8 (0.53) CCR8KCNH2GHSRMEN1KMT2A
Trifluoroacetic Acid SCHEMBL5426593 0.89 CCR8 (0.61) CCR8KCNH2CYP2D6CYP3A4TSHR
Trifluoroacetic Acid SCHEMBL5434664 0.89 CCR8 (0.52) CCR8KCNH2GHSRMEN1KMT2A
Trifluoroacetic Acid SCHEMBL5437579 0.89 CCR8 (0.52) CCR8KCNH2GHSRMEN1KMT2A
SCHEMBL5399610 0.88 CCR8 (0.53) CCR8KCNH2GHSRMEN1KMT2A
Trifluoroacetic Acid SCHEMBL5439733 0.87 CCR8 (0.50) CCR8KCNH2GHSRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249648-A1 Novel Diazaspiroalkanes and Their Use for Treatment of Ccr8 Mediated Diseases ASTRAZENECA AB (SE) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249648-A1 Novel Diazaspiroalkanes and Their Use for Treatment of Ccr8 Mediated Diseases CCR8, CCR1, CCR10 CCR8 1/4885KCNH2 2793/4885GHSR 1993/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.